Appropriate use criteria of left atrial appendage closure devices: latest evidences

References

• Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–528. PMID: 30700139. DOI:10.1161/CIR.0000000000000659
   PubMed Web of Science ®Google Scholar
• Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16(2):217–221. PMID: 31955707. DOI:10.1177/1747493019897870
   PubMed Web of Science ®Google Scholar
• Pistoia F, Sacco S, Tiseo C, et al. The epidemiology of atrial fibrillation and stroke. PMID: 27150174 Cardiol Clin. 2016;34(2):255–268. DOI: 10.1016/j.ccl.2015.12.002
   PubMed Web of Science ®Google Scholar
• Killu AM, Granger CB, Gersh BJ. Risk stratification for stroke in atrial fibrillation: a critique. PMID: 30508086 Eur Heart J. 2019;40(16):1294–1302. DOI: 10.1093/eurheartj/ehy731
   PubMed Web of Science ®Google Scholar
• van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA. 2002;288(19):2441–2448. PMID: 12435257. DOI: 10.1001/jama.288.19.2441
   PubMed Web of Science ®Google Scholar
• Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. PMID: 20299623 Chest. 2010;138(5):1093–1100. DOI: 10.1378/chest.10-0134
   PubMed Web of Science ®Google Scholar
• Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic Protection in Patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation. 2011;123(4):417–424. PMID: 33504742. DOI:10.1161/CIRCULATIONAHA.110.976449
   PubMed Web of Science ®Google Scholar
• Riva N, Smith DE, Lip GYH, et al. Advancing age and bleeding risk are the strongest barriers to anticoagulant prescription in atrial fibrillation. PMID: 21951858 Age Ageing. 2011;40(6):653–655. DOI: 10.1093/ageing/afr128
   PubMed Web of Science ®Google Scholar
• Angelini DE, Radivoyevitch T, McCrae KR, et al. Bleeding incidence and risk factors among cancer patients treated with anticoagulation. PMID: 31006890 Am J Hematol. 2019;94(7):780–785. DOI: 10.1002/ajh.25494
   PubMed Web of Science ®Google Scholar
• Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145(4):242–255. PMID: 34985309. DOI: 10.1161/CIRCULATIONAHA.121.056355
   PubMed Web of Science ®Google Scholar
• Kcükköylü S, Rump LC. DOAC use in patients with chronic kidney disease. Hamostaseologie. 2017;37(4):286–294.
   PubMed Web of Science ®Google Scholar
• Aaaa. 2000.
   Google Scholar
• Schellinger PD, Tsivgoulis G, Steiner T, et al. Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: review and critical appraisal. J Stroke. 2018 Sep;20(3):281–291. *(relevantreview. DOI:10.5853/jos.2018.02537
   PubMed Web of Science ®Google Scholar
• Lip GY. Does atrial fibrillation confer a hypercoagulable state? PMID: 7475767 Lancet. 1995;346(8986):1313–1314. DOI:10.1016/s0140-6736(95)92339-x
   PubMed Web of Science ®Google Scholar
• Goette A, Kalman JM, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace. 2016;18(10):1455–1490. PMID: 27402624. DOI: 10.1093/europace/euw161
   PubMed Web of Science ®Google Scholar
• Sanfilippo AJ, Abascal VM, Sheehan M, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation. 1990;82(3):792–797. PMID: 2144217. DOI: 10.1161/01.cir.82.3.792
   PubMed Web of Science ®Google Scholar
• Corradi D, Callegari S, Manotti L, et al. Persistent lone atrial fibrillation: clinicopathologic study of 19 cases. Heart Rhythm. 2014;11(7):1250–1258. PMID: 24560692. DOI: 10.1016/j.hrthm.2014.02.008
   PubMed Web of Science ®Google Scholar
• Tan KT, Lip GYH. Atrial fibrillation: should we target platelets or the coagulation pathway? PMID: 15071256 Card Electrophysiol Rev. 2003;7(4):370–371. DOI: 10.1023/B:CEPR.0000023141.17553.f1
   PubMedGoogle Scholar
• Markl M, Lee DC, Furiasse N, et al. Left atrial and left atrial appendage 4D blood flow dynamics in atrial fibrillation. Circ Cardiovasc Imaging. 2016;9(9):e004984. PMID: 27613699. DOI: 10.1161/CIRCIMAGING.116.004984
   PubMed Web of Science ®Google Scholar
• Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: virchow’s triad revisited. PMID: 19135613 Lancet. 2009;373(9658):155–166. DOI: 10.1016/S0140-6736(09)60040-4
   PubMed Web of Science ®Google Scholar
• Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart. 2012;98(15):1120–1126. PMID: 22572045. DOI: 10.1136/heartjnl-2012-301799.
   PubMed Web of Science ®Google Scholar
• Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. PMID: 8572814 Ann Thorac Surg. 1996;61(2):755–759. DOI: 10.1016/0003-4975(95)00887-X
   PubMed Web of Science ®Google Scholar
• Parekh A, Jaladi R, Sharma S, et al. The case of a disappearing left atrial appendage thrombus. Circulation. 2006;114(13):e513–514. PMID: 17000914. DOI: 10.1161/CIRCULATIONAHA.106.617886
   PubMed Web of Science ®Google Scholar
• Pollick C, Taylor D. Assessment of left atrial appendage function by transesophageal echocardiography. implications for the development of thrombus. Circulation. 1991;84(1):223–231. PMID: 2060098. DOI: 10.1161/01.cir.84.1.223
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
   PubMed Web of Science ®Google Scholar
• January CT, Wann LS, Calkins H, et al. AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation. 2019;140(2):e125–151. PMID: 30686041. DOI: 10.1161/CIR.0000000000000665
   PubMed Web of Science ®Google Scholar
• Boston Scientific Corporation. Assessment of the WATCHMANTM device in patients unsuitable for oral anticoagulation (ASAP-TOO). clinicaltrials.gov; 2023. cited Jan 4, 2023. Available from: https://clinicaltrials.gov/ct2/show/study/NCT02928497
   Google Scholar
• Landmesser U Left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding compared to medical therapy: a prospective randomized clinical trial. clinicaltrials.gov; 2021. cited Jan 4, 2023. Available from: https://clinicaltrials.gov/ct2/show/study/NCT03463317
   Google Scholar
• Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy. J Am Coll Cardiol. 2014;64(1):1–12. PMID: 24998121. DOI: 10.1016/j.jacc.2014.04.029
   PubMed Web of Science ®Google Scholar
• Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–542. PMID: 19683639. DOI: 10.1016/S0140-6736(09)61343-X
   PubMed Web of Science ®Google Scholar
• Osmancik P, Herman D, Neuzil P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122–3135. PMID: 32586585. DOI: 10.1016/j.jacc.2020.04.067
   PubMed Web of Science ®Google Scholar
• University of Aarhus. Left atrial appendage occlusion versus novel oral anticoagulation for stroke prevention in atrial fibrillation. A multicenter randomized clinical trial. (occlusion-AF). clinicaltrials.gov; 2021. cited Jan 4, 2023. Available from: https://clinicaltrials.gov/ct2/show/results/NCT03642509
   Google Scholar
• Nielsen-Kudsk JE, Johnsen SP, Wester P, et al. Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study. EuroIntervention. 2017;13(3):371–378. PMID: 28485276. DOI: 10.4244/EIJ-D-17-00201
   PubMed Web of Science ®Google Scholar
• Lempereur M, Aminian A, Freixa X, et al. Left atrial appendage occlusion in patients with atrial fibrillation and previous major gastrointestinal bleeding (from the amplatzer cardiac plug multicenter registry). Am J Cardiol. 2017;120(3):414–420. PMID: 28595859. DOI: 10.1016/j.amjcard.2017.04.046
   PubMed Web of Science ®Google Scholar
• Kefer J, Tzikas A, Freixa X, et al. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Int J Cardiol. 2016;207:335–340. PMID: 26820363. DOI: 10.1016/j.ijcard.2016.01.003
   PubMed Web of Science ®Google Scholar
• Rosenqvist PM Prevention of stroke by left atrial appendage closure in atrial fibrillation patients after intracerebral hemorrhage: a multicenter randomized clinical trial. clinicaltrials.gov; 2017. cited Jan 4, 2023. Available from: https://clinicaltrials.gov/ct2/show/results/NCT02830152
   Google Scholar
• Ozaki AF, Choi AS, Le QT, et al. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2020;13(3):e005969. PMID: 32148102. DOI: 10.1161/CIRCOUTCOMES.119.005969
   PubMed Web of Science ®Google Scholar
• Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EuroIntervention. 2020;15(13):1133–1180. PMID: 31474583. DOI: 10.4244/EIJY19M08_01
   PubMed Web of Science ®Google Scholar
• Falasconi G, Gaspardone C, Godino C, et al. Left atrial appendage closure: a new strategy for cardioembolic events despite oral anticoagulation. P Panminerva Med. 2021 Oct 19. DOI: 10.23736/S0031-0808.21.04446-3.
   PubMed Web of Science ®Google Scholar
• Sharma SP, Cheng J, Turagam MK, et al. Feasibility of left atrial appendage occlusion in left atrial appendage thrombus: a systematic review. JACC Clin Electrophysiol. 2020;6(4):414–424. DOI: 10.1016/j.jacep.2019.11.017
   PubMedGoogle Scholar
• Wintgens L, Romanov A, Phillips K, et al. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry. L Europace. 2018 Nov 1;20(11):1783–1789. DOI: 10.1093/europace/euy025
   PubMed Web of Science ®Google Scholar
• Gonzalez-Casal D, Datino T, Soto N, et al. Anatomy of the left atrial appendage for the interventional cardiologist. Herzschrittmacherther Elektrophysiol. 2022;33(2):195–202. PMID: 35606533. DOI: 10.1007/s00399-022-00866-8
   PubMedGoogle Scholar
• Lacomis JM, Goitein O, Deible C, et al. Dynamic multidimensional imaging of the human left atrial appendage. Europace. 2007;9(12):1134–1140. PMID: 17942583. DOI: 10.1093/europace/eum227
   PubMed Web of Science ®Google Scholar
• Słodowska K, Szczepanek E, Dudkiewicz D, et al. Morphology of the left atrial appendage: introduction of a new simplified shape-based classification system. Heart Lung Circ. 2021;30(7):1014–1022. PMID: 33582020. DOI: 10.1016/j.hlc.2020.12.006
   PubMed Web of Science ®Google Scholar
• Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531–538. PMID: 22858289. DOI: 10.1016/j.jacc.2012.04.032
   PubMed Web of Science ®Google Scholar
• Khurram IM, Dewire J, Mager M, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10(12):1843–1849. PMID: 24076444. DOI: 10.1016/j.hrthm.2013.09.065
   PubMed Web of Science ®Google Scholar
• Gilhofer TS, Saw J. Periprocedural imaging for left atrial appendage closure: computed tomography, transesophageal echocardiography, and intracardiac echocardiography. PMID: 32067648 Card Electrophysiol Clin. 2020;12(1):55–65. DOI: 10.1016/j.ccep.2019.11.007
   PubMedGoogle Scholar
• Sallach JA, Puwanant S, Drinko JK, et al. Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trial. J Am Soc Echocardiogr. 2009;22(10):1165–1172. PMID: 19647401. DOI: 10.1016/j.echo.2009.05.028
   PubMed Web of Science ®Google Scholar
• Manning WJ, Weintraub RM, Waksmonski CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med. 1995;123(11):817–822. PMID: 7486462. DOI: 10.7326/0003-4819-123-11-199512010-00001.
   PubMed Web of Science ®Google Scholar
• Nucifora G, Faletra FF, Regoli F, et al. Evaluation of the left atrial appendage with real-time 3-dimensional transesophageal echocardiography: implications for catheter-based left atrial appendage closure. Circ Cardiovasc Imaging. 2011;4(5):514–523. PMID: 21737601. DOI: 10.1161/CIRCIMAGING.111.963892
   PubMed Web of Science ®Google Scholar
• Wang DD, Eng M, Kupsky D, et al. Application of 3-dimensional computed tomographic image guidance to WATCHMAN implantation and impact on early operator learning curve: single-center experience. JACC: Cardiovasc Interv. 2016;9(22):2329–2340. PMID: 27884358. DOI: 10.1016/j.jcin.2016.07.038
   PubMed Web of Science ®Google Scholar
• Chow DH, Bieliauskas G, Sawaya FJ, et al. A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure. Open Heart. 2017;4(2):e000627. PMID: 28761682. DOI: 10.1136/openhrt-2017-000627
   PubMed Web of Science ®Google Scholar
• Saw J, Fahmy P, Spencer R, et al. Comparing measurements of CT angiography, TEE, and fluoroscopy of the left atrial appendage for percutaneous closure. J Cardiovasc Electrophysiol. 2016;27(4):414–422. PMID: 26728988. DOI: 10.1111/jce.12909
   PubMed Web of Science ®Google Scholar
• López-Mínguez JR, González-Fernández R, Fernández-Vegas C, et al. Comparison of imaging techniques to assess appendage anatomy and measurements for left atrial appendage closure device selection. J Invasive Cardiol. 2014;26(9):462–467. PMID: 25198490.
   PubMed Web of Science ®Google Scholar
• Goitein O, Fink N, Guetta V, et al. Printed MDCT 3D models for prediction of left atrial appendage (LAA) occluder device size: a feasibility study. EuroIntervention. 2017;13(9):e1076–1079. PMID: 28506939. DOI: 10.4244/EIJ-D-16-00921
   PubMed Web of Science ®Google Scholar
• Dallan LAP, Reed J, Yoon SH, et al. Novel cardiac magnetic resonance imaging-based sizing for left atrial appendage closure. J Cardiovasc Electrophysiol. 2022;33(12):2649–2650. PMID: 36300704. DOI:10.1111/jce.15720
   PubMed Web of Science ®Google Scholar
• Ward RC, Deshmukh AJ. Cardiac magnetic resonance imaging is a promising modality for left atrial appendage occlusion planning. PMID: 36300697 J Cardiovasc Electrophysiol. 2022;33(12):2651–2652. DOI: 10.1111/jce.15721
   PubMed Web of Science ®Google Scholar
• Yuniadi Y, Hanafy DA, Raharjo SB, et al. Left atrial appendage closure device implantation guided with fluoroscopy only: long-term results. PMID: 31007791 J Arrhythm. 2019;35(2):262–266. DOI: 10.1002/joa3.12151
   PubMed Web of Science ®Google Scholar
• Jungen C, Zeus T, Balzer J, et al. Left atrial appendage closure guided by integrated echocardiography and fluoroscopy imaging reduces radiation exposure. PLoS ONE. 2015;10(10):e0140386. PMID: 26465747. DOI: 10.1371/journal.pone.0140386.
   PubMed Web of Science ®Google Scholar
• Alkhouli M, Hijazi ZM, Holmes DR, et al. Intracardiac echocardiography in structural heart disease interventions. PMID: 30409271 JACC: Cardiovasc Interv. 2018;11(21):2133–2147. DOI: 10.1016/j.jcin.2018.06.056
   PubMed Web of Science ®Google Scholar
• Morcos R, Megaly M, Saad M, et al. In-hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure. Catheter Cardiovasc Interv. 2022;99(5):1572–1581. PMID: 35066997. DOI: 10.1002/ccd.30086.
   PubMed Web of Science ®Google Scholar
• Berti S, Pastormerlo LE, Santoro G, et al. Intracardiac versus transesophageal echocardiographic guidance for left atrial appendage occlusion: the LAAO italian multicenter registry. JACC: Cardiovasc Interv. 2018;11(11):1086–1092. DOI: 10.1016/j.jcin.2018.05.008. PMID: 29880104
   PubMed Web of Science ®Google Scholar
• Alkhouli M, Busu T, Shah K, et al. Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis. PMID: 30573129 JACC Clin Electrophysiol. 2018;4(12):1629–1637. DOI: 10.1016/j.jacep.2018.09.007
   PubMedGoogle Scholar
• Kleinecke C, Cheikh-Ibrahim M, Schnupp S, et al. Long-term clinical outcomes of amplatzer cardiac plug versus amulet occluders for left atrial appendage closure. Catheter Cardiovasc Interv. 2020;96(3):E324–331. PMID: 31631493. DOI:10.1002/ccd.28530
   PubMed Web of Science ®Google Scholar
• Litwinowicz R, Bartus M, Burysz M, et al. Long term outcomes after left atrial appendage closure with the LARIAT device—Stroke risk reduction over five years follow-up. PLoS ONE. 2018;13(12):e0208710. PMID 30566961. DOI: 10.1371/journal.pone.0208710
   PubMed Web of Science ®Google Scholar
• Bing S, Chen RR. Clinical efficacy and safety comparison of watchman device versus ACP/amulet device for percutaneous left atrial appendage closure in patients with nonvalvular atrial fibrillation: a study-level meta-analysis of clinical trials. Clin Cardiol. Published online Nov 30, 2022;46(2):117–125. PMID: 36448417. DOI: 10.1002/clc.23956
   PubMed Web of Science ®Google Scholar
• Gianni C, Di Biase L, Trivedi C, et al. Clinical implications of leaks following left atrial appendage ligation with the LARIAT device. JACC: Cardiovasc Interv. 2016;9(10):1051–1057. PMID: 27198686. DOI: 10.1016/j.jcin.2016.01.038
   PubMed Web of Science ®Google Scholar
• Abusnina W, Al-Abdouh A, Jaradeh H, et al. Comparative clinical outcomes of left atrial appendage occlusion with WATCHMAN device versus amplatzer cardiac plug/amulet occluder: a systematic review and meta-analysis. JACC Cardiovasc Interv. 2022;15:S70.
   Google Scholar
• Wang G, Kong B, Qin T, et al. Incidence, risk factors, and clinical impact of peridevice leak following left atrial appendage closure with the lAmbre device-data from a prospective multicenter clinical study. PMID: 33251673 J Cardiovasc Electrophysiol. 2021;32(2):354–359. DOI: 10.1111/jce.14824
   PubMed Web of Science ®Google Scholar
• Khumri TM, Thibodeau JB, Main ML. Transesophageal echocardiographic diagnosis of left atrial appendage occluder device infection. PMID: 17681493 Eur J Echocardiogr. 2008;9(4):565–566. DOI: 10.1016/j.euje.2007.06.005
   PubMed Web of Science ®Google Scholar
• Jensen J, Thaler C, Saxena R, et al. Transesophageal echocardiography to diagnose watchman device infection. CASE (Phila). 2020;4(3):189–194. PMID: 32577603. DOI: 10.1016/j.case.2020.01.008.
   PubMedGoogle Scholar
• Reddy VY, Sievert H, Halperin J, et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988–1998. DOI: 10.1001/jama.2014.15192
   PubMed Web of Science ®Google Scholar
• Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964–2975. PMID: 29103847. DOI: 10.1016/j.jacc.2017.10.021
   PubMed Web of Science ®Google Scholar
• Holmes DR, Doshi SK, Kar S, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: a patient-level meta-analysis. J Am Coll Cardiol. 2015;65(24):2614–2623. PMID: 26088300. DOI: 10.1016/j.jacc.2015.04.025
   PubMed Web of Science ®Google Scholar
• Holmes DR, Reddy VY, Gordon NT, et al. Long-term safety and efficacy in continued access left atrial appendage closure registries. J Am Coll Cardiol. 2019;74(23):2878–2889. PMID: 31806131. DOI: 10.1016/j.jacc.2019.09.064
   PubMed Web of Science ®Google Scholar
• Boersma LV, Ince H, Kische S, et al. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial. Heart Rhythm. 2017;14(9):1302–1308. PMID: 28577840. DOI: 10.1016/j.hrthm.2017.05.038
   PubMed Web of Science ®Google Scholar
• Freeman JV, Varosy P, Price MJ, et al. The NCDR left atrial appendage occlusion registry. J Am Coll Cardiol. 2020;75(13):1503–1518. PMID: 32238316. DOI: 10.1016/j.jacc.2019.12.040
   PubMed Web of Science ®Google Scholar
• Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013;61(25):2551–2556. PMID: 23583249. DOI: 10.1016/j.jacc.2013.03.035
   PubMed Web of Science ®Google Scholar
• Kar S, Doshi SK, Sadhu A, et al. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial. Circulation. 2021;143(18):1754–1762. PMID: 33820423. DOI: 10.1161/CIRCULATIONAHA.120.050117
   PubMed Web of Science ®Google Scholar
• Price MJ, Friedman DJ, Du C, et al. Comparative safety of transcatheter LAAO with the first-generation watchman and next-generation watchman FLX devices. JACC: Cardiovasc Interv. 2022;15(21):2115–2123. PMID: 36357014. DOI: 10.1016/j.jcin.2022.09.002
   PubMed Web of Science ®Google Scholar
• Fukuda N, Imamura T, Tanaka S, et al. Comparison in short-term safety and efficacy between new-generation WATCHMAN FLX and conventional WATCHMAN 2.5 for percutaneous left atrial appendage closure. J Clin Med. 2022:11(6);1618. DOI: 10.3390/jcm11061618.
   PubMed Web of Science ®Google Scholar
• Vizzari G, Grasso C, Sardone A, et al. Real-world experience with the new watchman FLX device: data from two high-volume sicilian centers. The FLX-Iest registry. Catheter Cardiovasc Interv. 2022;100(1):154–160. PMID: 35592941. DOI: 10.1002/ccd.30237
   PubMed Web of Science ®Google Scholar
• Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug. EuroIntervention. 2016;11(10):1170–1179. PMID: 25604089. DOI: 10.4244/EIJY15M01_06
   PubMed Web of Science ®Google Scholar
• Landmesser U, Tondo C, Camm J, et al. Left atrial appendage occlusion with the AMPLATZER amulet device: one-year follow-up from the prospective global amulet observational registry. EuroIntervention. 2018;14(5):e590–597. PMID: 29806820. DOI: 10.4244/EIJ-D-18-00344
   PubMed Web of Science ®Google Scholar
• Kleinecke C, Park JW, Gödde M, et al. Twelve-month follow-up of left atrial appendage occlusion with amplatzer amulet. PMID: 28198520 Cardiol J. 2017;24(2):131–138. DOI: 10.5603/CJ.a2017.0017
   PubMed Web of Science ®Google Scholar
• Qiao J, Zhang B, Wang J, et al. Comparison between amplatzer and watchman left atrial appendage closure devices for stroke prevention in atrial fibrillation: a systematic review and meta-analysis. Cardiol. 2022;147(3):290–297. PMID: 35468598. DOI: 10.1159/000524626
   PubMed Web of Science ®Google Scholar
• Lakkireddy D, Thaler D, Ellis CR, et al. Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial. Circulation. 2021;144(19):1543–1552. PMID: 34459659. DOI: 10.1161/CIRCULATIONAHA.121.057063
   PubMed Web of Science ®Google Scholar
• Fauchier L, Cinaud A, Brigadeau F, et al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528–1536. PMID: 29622159. DOI: 10.1016/j.jacc.2018.01.076
   PubMed Web of Science ®Google Scholar
• Garot P, Cormier B, Horvilleur J. Device-related thrombus after left atrial appendage closure. PMID: 30858891 Interv Cardiol. 2019;14(1):42–44. DOI: 10.15420/icr.2018.21.3
   PubMedGoogle Scholar
• Simard T, Jung RG, Lehenbauer K, et al. Predictors of device-related thrombus following percutaneous left atrial appendage occlusion. J Am Coll Cardiol. 2021;78(4):297–313.
   PubMed Web of Science ®Google Scholar
• Granier M, Laugaudin G, Massin F, et al. Occurrence of incomplete endothelialization causing residual permeability after left atrial appendage closure. J Invasive Cardiol. 2018;30(7):245–250. PMID: 29760285.
   PubMed Web of Science ®Google Scholar
• Saw J, Fahmy P, DeJong P, et al. Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. Eur Heart J Cardiovasc Imaging. 2015;16(11):1198–1206. PMID: 25851318. DOI: 10.1093/ehjci/jev067
   PubMed Web of Science ®Google Scholar
• Chung H, Jeon B, Chang HJ, et al. Predicting peri-device leakage of left atrial appendage device closure using novel three-dimensional geometric CT analysis. J Cardiovasc Ultrasound. 2015;23(4):211–218. PMID: 26755929. DOI:10.4250/jcu.2015.23.4.211
   PubMedGoogle Scholar
• Nguyen A, Gallet R, Riant E, et al. Peridevice leak after left atrial appendage closure: incidence, risk factors, and clinical impact. Can J Cardiol. 2019;35(4):405–412. PMID: 30935631. DOI: 10.1016/j.cjca.2018.12.022.
   PubMed Web of Science ®Google Scholar
• Dukkipati SR, Holmes DR, Doshi SK, et al. Impact of peridevice leak on 5-year outcomes after left atrial appendage closure. J Am Coll Cardiol. 2022;80(5):469–483. PMID: 35902169. DOI: 10.1016/j.jacc.2022.04.062
   PubMed Web of Science ®Google Scholar
• Galea R, De Marco F, Meneveau N, et al. Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial. Circulation. 2022;145(10):724–738. PMID: 34747186. DOI: 10.1161/CIRCULATIONAHA.121.057859
   PubMed Web of Science ®Google Scholar
• Basu Ray I, Khanra D, Shah S, et al. Meta-analysis comparing WatchmanTM and amplatzer devices for stroke prevention in atrial fibrillation. Front Cardiovasc Med. 2020;7:89. PMID: 32656246. DOI: 10.3389/fcvm.2020.00089
   PubMed Web of Science ®Google Scholar
• Korsholm K, Kramer A, Andersen A, et al. Left atrial appendage sealing performance of the amplatzer amulet and watchman FLX device. J Interv Card Electrophysiol. Published online Aug 11, 2022;66(2):391–401. PMID: 35951214. DOI: 10.1007/s10840-022-01336-4
   PubMed Web of Science ®Google Scholar
• Galea R, Mahmoudi K, Gräni C, et al. Watchman FLX vs. watchman 2.5 in a dual-center left atrial appendage closure cohort: the WATCH-DUAL study. Europace. 2022;24(9):1441–1450.
   PubMed Web of Science ®Google Scholar
• Lam YY. A new left atrial appendage occluder (lifetech lAmbre device) for stroke prevention in atrial fibrillation. PMID: 23773494 Cardiovasc Revasc Med. 2013;14(3):134–136. DOI: 10.1016/j.carrev.2013.04.003
   PubMedGoogle Scholar
• Jin LS, Ke JY, Lin YN, et al. Percutaneous left atrial appendage closure using the lAmbre device in patients with atrial fibrillation and left atrial appendage thrombus. Front Cardiovasc Med. 2022;9:1071119. PMID: 36505354. doi:10.3389/fcvm.2022.1071119.
   PubMed Web of Science ®Google Scholar
• Schnupp S, Liu XX, Buffle E, et al. Late clinical outcomes of lambre versus amplatzer occluders for left atrial appendage closure. J Cardiovasc Electrophysiol. 2020;31(4):934–942. PMID: 32072692. DOI: 10.1111/jce.14398
   PubMed Web of Science ®Google Scholar
• Huang H, Liu Y, Xu Y, et al. Percutaneous left atrial appendage closure with the lAmbre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study. JACC: Cardiovasc Interv. 2017;10(21):2188–2194. PMID: 29122133. DOI: 10.1016/j.jcin.2017.06.072
   PubMed Web of Science ®Google Scholar
• Gianni C, Anannab A, Sahore Salwan A, et al. Closure of the left atrial appendage using percutaneous transcatheter occlusion devices. PMID: 32249473 J Cardiovasc Electrophysiol. 2020;31(8):2179–2186. DOI: 10.1111/jce.14471
   PubMed Web of Science ®Google Scholar
• Medical C. WAveCrest vs. watchman TranssEptal LAA closure to rEduce AF-Mediated sTroke 2. A prospective, multicenter, randomized, active controlled, clinical trial of the coherex WaveCrest® left atrial appendage occlusion system compared to the watchman® LAA closure device for the reduction in risk of ischemic stroke or systemic embolism in subjects with non-valvular atrial fibrillation that have an appropriate rationale to seek a non-pharmacologic alternative to chronic oral anticoagulation. clinicaltrials.gov; 2022. cited Jan 12, 2023. Available from: https://clinicaltrials.gov/ct2/show/study/NCT03302494
   Google Scholar
• Bellmann B, Schnupp S, Kühnlein P, et al. Left atrial appendage closure with the new occlutech® device: first in man experience and neurological outcome. J Cardiovasc Electrophysiol. 2017;28(3):315–320. PMID: 27925332. DOI: 10.1111/jce.13141
   PubMed Web of Science ®Google Scholar
• Asmarats L, Masson JB, Pagnotta PA, et al. Percutaneous left atrial appendage closure with the ultraseal device: insights from the initial multicenter experience. JACC: Cardiovasc Interv. 2018;11(19):1932–1941. PMID: 30249439. DOI: 10.1016/j.jcin.2018.05.023
   PubMed Web of Science ®Google Scholar
• Pivato CA, Liccardo G, Sanz-Sanchez J, et al. Left atrial appendage closure with the II generation ultraseal device: an international registry. The LIGATE study. Catheter Cardiovasc Interv. 2022;100(4):620–627. PMID: 35842775. DOI: 10.1002/ccd.30336
   PubMed Web of Science ®Google Scholar
• Lee RJ, Lakkireddy D, Mittal S, et al. Percutaneous alternative to the maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and design. Am Heart J. 2015;170(6):1184–1194. PMID: 26678640. DOI: 10.1016/j.ahj.2015.09.019
   PubMed Web of Science ®Google Scholar
• Boersma LV, Ince H, Kische S, et al. Evaluating real-world clinical outcomes in atrial fibrillation patients receiving the WATCHMAN left atrial appendage closure technology: final 2-year outcome data of the EWOLUTION trial focusing on history of stroke and hemorrhage. Circ Arrhythm Electrophysiol. 2019;12(4):e006841. PMID: 3093990. DOI: 10.1161/CIRCEP.118.006841
   PubMed Web of Science ®Google Scholar
• Conformal Medical, Inc. An evaluation of the safety and effectiveness of the conformal CLAAS system for left atrial appendage occlusion. clinicaltrials.gov; 2023. cited Feb 14, 2023. Available from: https://clinicaltrials.gov/ct2/show/NCT05147792
   Google Scholar